The United States has reduced the additional tariff on Indian imports under its Section 301 measures, bringing the rate down from the proposed 12.5% to 10%.
The revision offers some relief to Indian exporters, although its impact will vary sharply across industries. Nearly 45% of India’s exports to the US are expected to remain unaffected, while the remaining 55% will attract the additional tariff alongside existing import duties.
India Secures Place in Lower Tariff Tier
The decision followed a Section 301 investigation by the Office of the United States Trade Representative into how 60 economies enforce restrictions on goods produced using forced labour.
India was placed in the 10% tariff tier rather than the initially proposed 12.5% bracket. The Commerce Ministry attributed the lower rate to India’s engagement with US authorities through written submissions, consultations and public hearings.
The revised rate also places Indian exporters in a relatively better position than exporters from several other economies covered by the investigation.
Pharmaceuticals and Smartphones Remain Exempt
Some of India’s most important export categories will not be covered by the additional 10% duty.
Generic pharmaceuticals, smartphones and certain other specified products will continue to receive exemptions. This means exporters in these categories will not face the new Section 301 levy.
Products already subject to separate Section 232 measures will also remain outside the scope of the new tariff. These include steel, aluminium and auto parts.
Together, these exemptions account for an estimated 45% of India’s exports to the United States.
Remaining 55% of Exports Face Additional Duty
The relief, however, does not extend across India’s entire export basket.
Around 55% of Indian exports to the US will be subject to the new 10% ad valorem tariff. The charge will be added to any import duties that already apply to those products.
The Commerce Ministry has said India’s overall tariff burden remains lower than that imposed on several other economies included in the Section 301 action.
For businesses outside the exempt categories, the practical effect will depend on the existing duties attached to their products and the final cost of supplying the US market.
India-US Trade Negotiations Continue
The tariff decision comes while India and the United States continue discussions on a proposed bilateral trade agreement.
The Indian government has said it remains committed to concluding the agreement at the earliest while protecting the interests of domestic exporters.
A textile-specific mechanism referred to in the US announcement has not yet been put into operation. Indian officials are continuing discussions with Washington on how that mechanism may work.
Until those details are settled, exporters in non-exempt sectors will continue to watch the negotiations closely.
Partial Relief, Not a Complete Exemption
The reduction from 12.5% to 10% softens the immediate impact on Indian goods, but it does not remove the additional tariff for most exports.
The clearest relief is concentrated in categories such as generic medicines and smartphones, along with steel, aluminium and auto parts that are already covered by other US trade measures.
For the rest of India’s exporters, the new 10% duty will become an additional cost of accessing the American market. The next major development will depend on the progress of bilateral trade negotiations and any further clarification from the two governments.
